{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:33:06Z","timestamp":1793701986161,"version":"4.5.1"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473384"],"award-info":[{"award-number":["82473384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472716"],"award-info":[{"award-number":["82472716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82125029"],"award-info":[{"award-number":["82125029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073106"],"award-info":[{"award-number":["82073106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341016"],"award-info":[{"award-number":["82341016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002956"],"award-info":[{"award-number":["82002956"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402041"],"award-info":[{"award-number":["81402041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Projects in Guangzhou","award":["2023A03J0390"],"award-info":[{"award-number":["2023A03J0390"]}]},{"name":"Science and Technology Projects in Guangzhou","award":["202201011371"],"award-info":[{"award-number":["202201011371"]}]},{"name":"Guangdong Provincial and Applied Basic Research Foundation","award":["2024A1515013254"],"award-info":[{"award-number":["2024A1515013254"]}]},{"name":"Guangdong Provincial and Applied Basic Research Foundation","award":["2023A1515220076"],"award-info":[{"award-number":["2023A1515220076"]}]},{"name":"Guangdong Provincial and Applied Basic Research Foundation","award":["2022A1515110283"],"award-info":[{"award-number":["2022A1515110283"]}]},{"name":"Guangdong Provincial and Applied Basic Research Foundation","award":["2021A1515220059"],"award-info":[{"award-number":["2021A1515220059"]}]},{"name":"Guangdong Provincial and Applied Basic Research Foundation","award":["2019A1515110149"],"award-info":[{"award-number":["2019A1515110149"]}]},{"name":"Shenzheng Science and Technology Innovation Commission Foundation","award":["JCYJ20190806160412946"],"award-info":[{"award-number":["JCYJ20190806160412946"]}]},{"name":"Shenzheng Science and Technology Innovation Commission Foundation","award":["JCYJ20220818101401003)"],"award-info":[{"award-number":["JCYJ20220818101401003)"]}]},{"name":"Shenzhen Key Medical Discipline Construction Fund","award":["SZXK015"],"award-info":[{"award-number":["SZXK015"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cleavage stimulation factor subunit 2 (CSTF2) is a fundamental factor in the regulation of 3\u2032-end cleavage and alternative polyadenylation of pre-mRNAs. Previous work has identified a tumor-promoting role of CSTF2, suggesting that it may represent a potential therapeutic target. In this study, we aimed to elucidate the mechanistic function of CSTF2 in hepatocellular carcinoma (HCC). CSTF2 upregulation was frequent in HCC, and elevated levels of CSTF2 correlated with poor patient prognosis. Although CSTF2 inhibition did not suppress HCC growth under nonstress conditions, it supported tolerance and survival of HCC cells under hypoxic conditions. Mechanistically, CSTF2 increased phosphoglycerate kinase 1 (PGK1) protein production to enhance glycolysis, thereby sustaining the energy supply under hypoxic conditions. CSTF2 shortened the 3\u2032 untranslated region of PGK1 pre-mRNA by binding near the proximal polyadenylation site. This shortening led to a loss of N6-methyladenosine (m6A) modification sites that are bound by YTH m6A RNA-binding protein F2 and increase degradation of PGK1 mRNA. Concurrently, hypoxia increased m6A modification of PGK1 mRNA near the proximal polyadenylation site that was recognized by the YTH m6A RNA-binding protein C1, which recruited CSTF2 to enhance the shortening of the PGK1 3\u2032 untranslated region. A small-molecule screen identified masitinib as an inhibitor of CSTF2. Masitinib counteracted PGK1 upregulation by CSTF2 and suppressed the growth of HCC xenograft and patient-derived organoid models. In conclusion, this study revealed a function of CSTF2 in supporting HCC survival under hypoxia conditions through m6A modification evasion and metabolic reprogramming, indicating that inhibiting CSTF2 may overcome hypoxia tolerance in HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Targeting CSTF2 inhibits hepatocellular carcinoma survival in hypoxic microenvironments, which may be a promising therapeutic strategy for treating liver cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-24-2283","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T12:42:56Z","timestamp":1731069776000},"page":"515-534","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["CSTF2 Supports Hypoxia Tolerance in Hepatocellular Carcinoma by Enabling m6A Modification Evasion of PGK1 to Enhance Glycolysis"],"prefix":"10.1158","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0386-1506","authenticated-orcid":false,"given":"Qiangnu","family":"Zhang","sequence":"first","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."},{"name":"2Biomedicine Research Center, Guangdong Provincial Key Laboratory of Major Obstetric Disease, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6123-1828","authenticated-orcid":false,"given":"Yusen","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6722-1017","authenticated-orcid":false,"given":"Chuli","family":"Fu","sequence":"additional","affiliation":[{"name":"3Department of Hematology and Oncology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2732-4999","authenticated-orcid":false,"given":"Xiaoyan","family":"He","sequence":"additional","affiliation":[{"name":"4Department of Pathology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4688-5820","authenticated-orcid":false,"given":"Zuotian","family":"Huang","sequence":"additional","affiliation":[{"name":"5Department of Hepatobiliary and Pancreatic Tumor Center, Chongqing University Cancer Hospital, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8034-9592","authenticated-orcid":false,"given":"Geyan","family":"Wu","sequence":"additional","affiliation":[{"name":"2Biomedicine Research Center, Guangdong Provincial Key Laboratory of Major Obstetric Disease, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-2848","authenticated-orcid":false,"given":"Teng","family":"Wei","sequence":"additional","affiliation":[{"name":"6Cytotherapy Laboratory, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2085-4340","authenticated-orcid":false,"given":"Wen","family":"Jin","sequence":"additional","affiliation":[{"name":"7Department of Neurology, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4854-5689","authenticated-orcid":false,"given":"Lesen","family":"Yan","sequence":"additional","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7261-179X","authenticated-orcid":false,"given":"Meilong","family":"Wu","sequence":"additional","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8308-2715","authenticated-orcid":false,"given":"Gongze","family":"Peng","sequence":"additional","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8684-2010","authenticated-orcid":false,"given":"LinLan","family":"Fan","sequence":"additional","affiliation":[{"name":"8Experimental and teaching Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5384-4786","authenticated-orcid":false,"given":"Mingyue","family":"Li","sequence":"additional","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4567-9683","authenticated-orcid":false,"given":"Yuehua","family":"Guo","sequence":"additional","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0641-5466","authenticated-orcid":false,"given":"Jiangang","family":"Bi","sequence":"additional","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5944-2564","authenticated-orcid":false,"given":"Yu","family":"Bai","sequence":"additional","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-5942","authenticated-orcid":false,"given":"Stephanie","family":"Roessler","sequence":"additional","affiliation":[{"name":"9Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4859-8710","authenticated-orcid":false,"given":"Guang-Rong","family":"Yan","sequence":"additional","affiliation":[{"name":"2Biomedicine Research Center, Guangdong Provincial Key Laboratory of Major Obstetric Disease, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7017-301X","authenticated-orcid":false,"given":"Liping","family":"Liu","sequence":"additional","affiliation":[{"name":"1Division of Hepatobiliary and Pancreas Surgery, Department of General Surgery, Shenzhen People\u2019s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"2026042309512316500_bib1","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1158\/0008-5472.CAN-18-0822","article-title":"CSTF2-Induced shortening of the RAC1 3\u2032UTR promotes the pathogenesis of urothelial carcinoma of the bladder","volume":"78","author":"Chen","year":"2018","journal-title":"Cancer Res"},{"key":"2026042309512316500_bib2","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1093\/nar\/gkaa689","article-title":"A missense mutation in the CSTF2 gene that impairs the function of the RNA recognition motif and causes defects in 3\u2032 end processing is associated with intellectual disability in humans","volume":"48","author":"Grozdanov","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2026042309512316500_bib3","doi-asserted-by":"crossref","first-page":"18773","DOI":"10.1073\/pnas.1211101109","article-title":"Transcriptome-wide analyses of CstF64-RNA interactions in global regulation of mRNA alternative polyadenylation","volume":"109","author":"Yao","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042309512316500_bib4","doi-asserted-by":"crossref","first-page":"897804","DOI":"10.3389\/fonc.2022.897804","article-title":"CSTF2 promotes hepatocarcinogenesis and hepatocellular carcinoma progression via aerobic glycolysis","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"2026042309512316500_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.hbpd.2023.06.011","article-title":"Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma","volume":"23","author":"Shi","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2026042309512316500_bib6","doi-asserted-by":"crossref","first-page":"e12572","DOI":"10.7717\/peerj.12572","article-title":"A novel machine learning derived RNA-binding protein gene-based score system predicts prognosis of hepatocellular carcinoma patients","volume":"9","author":"Zhang","year":"2021","journal-title":"PeerJ"},{"key":"2026042309512316500_bib7","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1111\/jcmm.16249","article-title":"A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma","volume":"25","author":"Zhang","year":"2021","journal-title":"J Cell Mol Med"},{"key":"2026042309512316500_bib8","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.18632\/aging.202723","article-title":"Hypoxia associated multi-omics molecular landscape of tumor tissue in patients with hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"2026042309512316500_bib9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijbiomac.2022.12.044","article-title":"The RNA-binding protein CSTF2 regulates BAD to inhibit apoptosis in glioblastoma","volume":"226","author":"Xu","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"2026042309512316500_bib10","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1158\/0008-5472.CAN-21-1201","article-title":"CstF64-Induced shortening of the BID 3\u2032UTR promotes esophageal squamous cell carcinoma progression by disrupting ceRNA cross-talk with ZFP36L2","volume":"81","author":"Lin","year":"2021","journal-title":"Cancer Res"},{"key":"2026042309512316500_bib11","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41388-023-02665-y","article-title":"Hypoxia-responsive PPARGC1A\/BAMBI\/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma","volume":"42","author":"Zhang","year":"2023","journal-title":"Oncogene"},{"key":"2026042309512316500_bib12","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/cells10071715","article-title":"Hypoxia, metabolic reprogramming, and drug resistance in liver cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"key":"2026042309512316500_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2478\/jtim-2022-0022","article-title":"Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma","volume":"11","author":"Shen","year":"2022","journal-title":"J Transl Int Med"},{"key":"2026042309512316500_bib14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.31448","article-title":"MiR-125b loss activated HIF1\u03b1\/pAKT loop, leading to transarterial chemoembolization resistance in hepatocellular carcinoma","volume":"73","author":"Wei","year":"2021","journal-title":"Hepatology"},{"key":"2026042309512316500_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13046-020-01605-y","article-title":"PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma","volume":"39","author":"Martin","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"2026042309512316500_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0159-1","article-title":"Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors","volume":"50","author":"M\u00e9ndez-Blanco","year":"2018","journal-title":"Exp Mol Med"},{"key":"2026042309512316500_bib17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41467-022-28618-9","article-title":"Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"2026042309512316500_bib18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"2026042309512316500_bib19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.32419","article-title":"Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC","volume":"76","author":"Suthen","year":"2022","journal-title":"Hepatology"},{"key":"2026042309512316500_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","article-title":"Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1\u03b1\/PPAR-\u03b3\/PKM2-mediated glycolysis","volume":"39","author":"Feng","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"2026042309512316500_bib21","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.7150\/thno.72581","article-title":"mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"2026042309512316500_bib22","doi-asserted-by":"crossref","first-page":"117863","DOI":"10.1016\/j.lfs.2020.117863","article-title":"Phosphoglycerate kinase 1 (PGK1) in cancer: a promising target for diagnosis and therapy","volume":"256","author":"Fu","year":"2020","journal-title":"Life Sci"},{"key":"2026042309512316500_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.28887","article-title":"Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis","volume":"65","author":"Hu","year":"2017","journal-title":"Hepatology"},{"key":"2026042309512316500_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2009.06.016","article-title":"Widespread shortening of 3\u2032UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells","volume":"138","author":"Mayr","year":"2009","journal-title":"Cell"},{"key":"2026042309512316500_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2019.114430","article-title":"CFIm25 and alternative polyadenylation: conflicting roles in cancer","volume":"459","author":"Jafari Najaf Abadi","year":"2019","journal-title":"Cancer Lett"},{"key":"2026042309512316500_bib26","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-22-0909","article-title":"An alternatively spliced p62 isoform confers resistance to chemotherapy in breast cancer","volume":"82","author":"Guo","year":"2022","journal-title":"Cancer Res"},{"key":"2026042309512316500_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-021-01884-z","article-title":"CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression","volume":"40","author":"Tan","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"2026042309512316500_bib28","doi-asserted-by":"crossref","first-page":"984453","DOI":"10.3389\/fphar.2022.984453","article-title":"The role of RNA modification in hepatocellular carcinoma","volume":"13","author":"Feng","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026042309512316500_bib29","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1080\/22221751.2021.2006580","article-title":"Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification","volume":"10","author":"Kostyusheva","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"2026042309512316500_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40164-022-00298-7","article-title":"Role of m6A writers, erasers and readers in cancer","volume":"11","author":"Fang","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"2026042309512316500_bib31","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1093\/nar\/gkac251","article-title":"m6A and YTHDF proteins contribute to the localization of select neuronal mRNAs","volume":"50","author":"Flamand","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2026042309512316500_bib32","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","article-title":"A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA","volume":"181","author":"Zaccara","year":"2020","journal-title":"Cell"},{"key":"2026042309512316500_bib33","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1038\/s41467-023-41861-y","article-title":"CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes","volume":"14","author":"Zheng","year":"2023","journal-title":"Nat Commun"},{"key":"2026042309512316500_bib34","doi-asserted-by":"crossref","first-page":"679367","DOI":"10.3389\/fonc.2021.679367","article-title":"m6A modification: a double-edged sword in tumor development","volume":"11","author":"Gao","year":"2021","journal-title":"Front Oncol"},{"key":"2026042309512316500_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.critrevonc.2013.12.011","article-title":"Masitinib (AB1010), from canine tumor model to human clinical development: where we are?","volume":"91","author":"Marech","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026042309512316500_bib36","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdv133","article-title":"A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer","volume":"26","author":"Deplanque","year":"2015","journal-title":"Ann Oncol"},{"key":"2026042309512316500_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00280-010-1299-8","article-title":"Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer","volume":"66","author":"Mitry","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026042309512316500_bib38","doi-asserted-by":"crossref","first-page":"175183","DOI":"10.1016\/j.ejphar.2022.175183","article-title":"c-kit inhibitor masitinib induces reactive oxygen species-dependent apoptosis in c-kit-negative HepG2 cells","volume":"931","author":"Semba","year":"2022","journal-title":"Eur J Pharmacol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-2283\/3517045\/can-24-2283.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/3\/515\/3537593\/can-24-2283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/3\/515\/3537593\/can-24-2283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:51:36Z","timestamp":1776952296000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/85\/3\/515\/751287\/CSTF2-Supports-Hypoxia-Tolerance-in-Hepatocellular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,11,8]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-2283","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.28347042","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.28344617","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.28344614","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.28347045","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.28347039","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.28344620","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.7653965","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}